Technology for enhancing generation and efficacy of stem cells-derived exosome through thrombin Priming

Item Number: 585
Industry: Therapeutic
Category: Stem Cells
Development Stage: Early Stage
Organisation Type: Private Corporation
Country: South Korea
Patent: Korea, PCT
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


Thrombin treated stem cell-derived technology for promoting exosome production and enhancing its efficacy

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it